These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35117346)

  • 21. Combination of Kras activation and PTEN deletion contributes to murine hepatopancreatic ductal malignancy.
    Lin YK; Fang Z; Jiang TY; Wan ZH; Pan YF; Ma YH; Shi YY; Tan YX; Dong LW; Zhang YJ; Wang HY
    Cancer Lett; 2018 May; 421():161-169. PubMed ID: 29452147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TBX2 represses PTEN in rhabdomyosarcoma and skeletal muscle.
    Zhu B; Zhang M; Williams EM; Keller C; Mansoor A; Davie JK
    Oncogene; 2016 Aug; 35(32):4212-24. PubMed ID: 26686089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway.
    Bi X; Lv X; Liu D; Guo H; Yao G; Wang L; Liang X; Yang Y
    Cancer Gene Ther; 2021 Apr; 28(3-4):335-349. PubMed ID: 32939058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcoma.
    Guenther MK; Graab U; Fulda S
    Cancer Lett; 2013 Sep; 337(2):200-9. PubMed ID: 23684925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in gynecologic tumor development in Amhr2-Cre mice with KRAS
    Kun EHS; Tsang YTM; Lin S; Pan S; Medapalli T; Malpica A; Richards JS; Gershenson DM; Wong KK
    Sci Rep; 2020 Nov; 10(1):20678. PubMed ID: 33244099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wild-type tumor repressor protein 53 (Trp53) promotes ovarian cancer cell survival.
    Mullany LK; Liu Z; King ER; Wong KK; Richards JS
    Endocrinology; 2012 Apr; 153(4):1638-48. PubMed ID: 22396451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arid1a inactivation in an Apc- and Pten-defective mouse ovarian cancer model enhances epithelial differentiation and prolongs survival.
    Zhai Y; Kuick R; Tipton C; Wu R; Sessine M; Wang Z; Baker SJ; Fearon ER; Cho KR
    J Pathol; 2016 Jan; 238(1):21-30. PubMed ID: 26279473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutual contribution of Pten and estrogen to endometrial carcinogenesis in a PtenloxP/loxP mouse model.
    Saito F; Tashiro H; To Y; Ohtake H; Ohba T; Suzuki A; Katabuchi H
    Int J Gynecol Cancer; 2011 Nov; 21(8):1343-9. PubMed ID: 21989218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levels of PTEN protein modulate Akt phosphorylation on serine 473, but not on threonine 308, in IGF-II-overexpressing rhabdomyosarcomas cells.
    Wan X; Helman LJ
    Oncogene; 2003 Nov; 22(50):8205-11. PubMed ID: 14603261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice.
    Kinross KM; Montgomery KG; Kleinschmidt M; Waring P; Ivetac I; Tikoo A; Saad M; Hare L; Roh V; Mantamadiotis T; Sheppard KE; Ryland GL; Campbell IG; Gorringe KL; Christensen JG; Cullinane C; Hicks RJ; Pearson RB; Johnstone RW; McArthur GA; Phillips WA
    J Clin Invest; 2012 Feb; 122(2):553-7. PubMed ID: 22214849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of a MEK inhibitor at sub-MTD with a PI3K/mTOR inhibitor significantly suppresses growth of lung adenocarcinoma tumors in Kras(G12D-LSL) mice.
    Simmons BH; Lee JH; Lalwani K; Giddabasappa A; Snider BA; Wong A; Lappin PB; Eswaraka J; Kan JL; Christensen JG; Shojaei F
    Cancer Chemother Pharmacol; 2012 Aug; 70(2):213-20. PubMed ID: 22684718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Truncated Bid Overexpression Induced by Recombinant Adenovirus Cre/LoxP System Suppresses the Tumorigenic Potential of CD133
    Long Q; Zhu W; Zhou J; Wu J; Lu W; Zheng C; Zhou D; Yu L; Yang R
    Oncol Res; 2017 Apr; 25(4):595-603. PubMed ID: 27760587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenovirus-mediated truncated Bid overexpression induced by the Cre/LoxP system promotes the cell apoptosis of CD133+ ovarian cancer stem cells.
    Long Q; Yang R; Lu W; Zhu W; Zhou J; Zheng C; Zhou D; Yu L; Wu J
    Oncol Rep; 2017 Jan; 37(1):155-162. PubMed ID: 27878291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted DNA recombination in vivo using an adenovirus carrying the cre recombinase gene.
    Wang Y; Krushel LA; Edelman GM
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3932-6. PubMed ID: 8632992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PTEN loss in the fallopian tube induces hyperplasia and ovarian tumor formation.
    Russo A; Czarnecki AA; Dean M; Modi DA; Lantvit DD; Hardy L; Baligod S; Davis DA; Wei JJ; Burdette JE
    Oncogene; 2018 Apr; 37(15):1976-1990. PubMed ID: 29367766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner.
    Yan X; Fraser M; Qiu Q; Tsang BK
    Gynecol Oncol; 2006 Aug; 102(2):348-55. PubMed ID: 16545436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. K-Ras and p53 mouse model with molecular characteristics of human rhabdomyosarcoma and translational applications.
    Nakahata K; Simons BW; Pozzo E; Shuck R; Kurenbekova L; Prudowsky Z; Dholakia K; Coarfa C; Patel TD; Donehower LA; Yustein JT
    Dis Model Mech; 2022 Feb; 15(2):. PubMed ID: 35174853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion.
    Ikenoue T; Terakado Y; Nakagawa H; Hikiba Y; Fujii T; Matsubara D; Noguchi R; Zhu C; Yamamoto K; Kudo Y; Asaoka Y; Yamaguchi K; Ijichi H; Tateishi K; Fukushima N; Maeda S; Koike K; Furukawa Y
    Sci Rep; 2016 Apr; 6():23899. PubMed ID: 27032374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenovirus mediated homozygous endometrial epithelial Pten deletion results in aggressive endometrial carcinoma.
    Joshi A; Ellenson LH
    Exp Cell Res; 2011 Jul; 317(11):1580-9. PubMed ID: 21397598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamics of PI3K and Hippo signaling pathways during in vitro human follicle activation.
    Grosbois J; Demeestere I
    Hum Reprod; 2018 Sep; 33(9):1705-1714. PubMed ID: 30032281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.